BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

855 related articles for article (PubMed ID: 28662398)

  • 1. Evaluation of ultrasmall superparamagnetic iron-oxide (USPIO) enhanced MRI with ferumoxytol to quantify arterial wall inflammation.
    Smits LP; Tiessens F; Zheng KH; Stroes ES; Nederveen AJ; Coolen BF
    Atherosclerosis; 2017 Aug; 263():211-218. PubMed ID: 28662398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of atherosclerotic plaques on (18)F-FDG PET/MRI: comparison with a PET/CT hybrid system.
    Li X; Heber D; Rausch I; Beitzke D; Mayerhoefer ME; Rasul S; Kreissl M; Mitthauser M; Wadsak W; Hartenbach M; Haug A; Zhang X; Loewe C; Beyer T; Hacker M
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1503-12. PubMed ID: 26816195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thresholds for Arterial Wall Inflammation Quantified by
    van der Valk FM; Verweij SL; Zwinderman KA; Strang AC; Kaiser Y; Marquering HA; Nederveen AJ; Stroes ES; Verberne HJ; Rudd JH
    JACC Cardiovasc Imaging; 2016 Oct; 9(10):1198-1207. PubMed ID: 27639759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
    Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.
    Millon A; Dickson SD; Klink A; Izquierdo-Garcia D; Bini J; Lancelot E; Ballet S; Robert P; Mateo de Castro J; Corot C; Fayad ZA
    Atherosclerosis; 2013 Jun; 228(2):339-45. PubMed ID: 23582588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of methods for magnetic resonance-guided [18-F]fluorodeoxyglucose positron emission tomography in human carotid arteries: reproducibility, partial volume correction, and correlation between methods.
    Izquierdo-Garcia D; Davies JR; Graves MJ; Rudd JH; Gillard JH; Weissberg PL; Fryer TD; Warburton EA
    Stroke; 2009 Jan; 40(1):86-93. PubMed ID: 18927453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability.
    Metz S; Beer AJ; Settles M; Pelisek J; Botnar RM; Rummeny EJ; Heider P
    Int J Cardiovasc Imaging; 2011 Jul; 27(6):901-12. PubMed ID: 20972832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease.
    Tang TY; Howarth SP; Miller SR; Graves MJ; Patterson AJ; U-King-Im JM; Li ZY; Walsh SR; Brown AP; Kirkpatrick PJ; Warburton EA; Hayes PD; Varty K; Boyle JR; Gaunt ME; Zalewski A; Gillard JH
    J Am Coll Cardiol; 2009 Jun; 53(22):2039-50. PubMed ID: 19477353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques in patients with asymptomatic carotid stenosis undergoing coronary artery bypass grafting: an ultrasmall superparamagnetic iron oxide enhanced magnetic resonance study.
    Tang TY; Howarth SP; Miller SR; Graves MJ; U-King-Im JM; Li ZY; Walsh SR; Hayes PD; Varty K; Gillard JH
    Eur J Vasc Endovasc Surg; 2008 Apr; 35(4):392-8. PubMed ID: 18171628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferumoxytol-enhanced magnetic resonance imaging methodology and normal values at 1.5 and 3T.
    Stirrat CG; Alam SR; MacGillivray TJ; Gray CD; Forsythe R; Dweck MR; Payne JR; Prasad SK; Petrie MC; Gardner RS; Mirsadraee S; Henriksen PA; Newby DE; Semple SI
    J Cardiovasc Magn Reson; 2016 Jul; 18(1):46. PubMed ID: 27465647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI.
    Tang T; Howarth SP; Miller SR; Trivedi R; Graves MJ; King-Im JU; Li ZY; Brown AP; Kirkpatrick PJ; Gaunt ME; Gillard JH
    Stroke; 2006 Sep; 37(9):2266-70. PubMed ID: 16917091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined PET-FDG and USPIO-enhanced MR imaging in patients with symptomatic moderate carotid artery stenosis.
    Tang TY; Moustafa RR; Howarth SP; Walsh SR; Boyle JR; Li ZY; Baron JC; Gillard JH; Warburton EA
    Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):53-5. PubMed ID: 18396074
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Vesey AT; Jenkins WS; Irkle A; Moss A; Sng G; Forsythe RO; Clark T; Roberts G; Fletcher A; Lucatelli C; Rudd JH; Davenport AP; Mills NL; Al-Shahi Salman R; Dennis M; Whiteley WN; van Beek EJ; Dweck MR; Newby DE
    Circ Cardiovasc Imaging; 2017 Mar; 10(3):e004976. PubMed ID: 28292859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron Emission Tomography and Magnetic Resonance Imaging of Cellular Inflammation in Patients with Abdominal Aortic Aneurysms.
    McBride OM; Joshi NV; Robson JM; MacGillivray TJ; Gray CD; Fletcher AM; Dweck MR; van Beek EJ; Rudd JH; Newby DE; Semple SI
    Eur J Vasc Endovasc Surg; 2016 Apr; 51(4):518-26. PubMed ID: 26919936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary carotid imaging: from degree of stenosis to plaque vulnerability.
    Brinjikji W; Huston J; Rabinstein AA; Kim GM; Lerman A; Lanzino G
    J Neurosurg; 2016 Jan; 124(1):27-42. PubMed ID: 26230478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of supra-aortic arterial wall inflammation in patients with arteritis using high resolution dynamic contrast-enhanced magnetic resonance imaging: initial results in correlation to [18F]-FDG PET/CT.
    Cyran CC; Sourbron S; Bochmann K; Habs M; Pfefferkorn T; Rominger A; Raya JG; Reiser MF; Dichgans M; Nikolaou K; Hacker M; Saam T
    Invest Radiol; 2011 Sep; 46(9):594-9. PubMed ID: 21577125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque.
    Saito H; Kuroda S; Hirata K; Magota K; Shiga T; Tamaki N; Yoshida D; Terae S; Nakayama N; Houkin K
    Cerebrovasc Dis; 2013; 35(4):370-7. PubMed ID: 23635390
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Johnsrud K; Skagen K; Seierstad T; Skjelland M; Russell D; Revheim ME
    J Nucl Cardiol; 2019 Jun; 26(3):883-893. PubMed ID: 29209949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging.
    Hyafil F; Schindler A; Sepp D; Obenhuber T; Bayer-Karpinska A; Boeckh-Behrens T; Höhn S; Hacker M; Nekolla SG; Rominger A; Dichgans M; Schwaiger M; Saam T; Poppert H
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):270-279. PubMed ID: 26433367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality imaging of carotid artery plaques: 18F-fluoro-2-deoxyglucose positron emission tomography, computed tomography, and magnetic resonance imaging.
    Kwee RM; Teule GJ; van Oostenbrugge RJ; Mess WH; Prins MH; van der Geest RJ; Ter Berg JW; Franke CL; Korten AG; Meems BJ; Hofman PA; van Engelshoven JM; Wildberger JE; Kooi ME
    Stroke; 2009 Dec; 40(12):3718-24. PubMed ID: 19875738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.